NO954542D0 - 1-Arylcykloalkylsulfider, -sulfoksyder og sulfoner for behandling av depresjon, angst og Parkinson's sykdom - Google Patents

1-Arylcykloalkylsulfider, -sulfoksyder og sulfoner for behandling av depresjon, angst og Parkinson's sykdom

Info

Publication number
NO954542D0
NO954542D0 NO954542A NO954542A NO954542D0 NO 954542 D0 NO954542 D0 NO 954542D0 NO 954542 A NO954542 A NO 954542A NO 954542 A NO954542 A NO 954542A NO 954542 D0 NO954542 D0 NO 954542D0
Authority
NO
Norway
Prior art keywords
pct
optionally substituted
anxiety
parkinson
depression
Prior art date
Application number
NO954542A
Other languages
English (en)
Other versions
NO305165B1 (no
NO954542L (no
Inventor
Paul John Harris
David John Heal
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO954542D0 publication Critical patent/NO954542D0/no
Publication of NO954542L publication Critical patent/NO954542L/no
Publication of NO305165B1 publication Critical patent/NO305165B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO954542A 1993-05-12 1995-11-10 1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse derav NO305165B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309749A GB9309749D0 (en) 1993-05-12 1993-05-12 Therapeutic agents
PCT/EP1994/001494 WO1994026704A1 (en) 1993-05-12 1994-05-07 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease

Publications (3)

Publication Number Publication Date
NO954542D0 true NO954542D0 (no) 1995-11-10
NO954542L NO954542L (no) 1996-01-10
NO305165B1 NO305165B1 (no) 1999-04-12

Family

ID=10735317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954542A NO305165B1 (no) 1993-05-12 1995-11-10 1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse derav

Country Status (29)

Country Link
US (1) US5652271A (no)
EP (1) EP0715620B1 (no)
JP (2) JP3606326B2 (no)
KR (1) KR100295264B1 (no)
AT (1) ATE172719T1 (no)
AU (1) AU681669B2 (no)
BG (1) BG61913B1 (no)
BR (2) BR9406577A (no)
CZ (1) CZ290711B6 (no)
DE (1) DE69414264T2 (no)
DK (1) DK0715620T3 (no)
ES (1) ES2124411T3 (no)
FI (1) FI955429A (no)
GB (1) GB9309749D0 (no)
HU (1) HU211124A9 (no)
IL (1) IL109635A (no)
LV (1) LV11320A (no)
MY (1) MY110773A (no)
NO (1) NO305165B1 (no)
NZ (1) NZ266776A (no)
PH (1) PH30418A (no)
PL (1) PL176400B1 (no)
RO (1) RO115519B1 (no)
RU (1) RU2135467C1 (no)
SK (1) SK281257B6 (no)
TW (1) TW318833B (no)
UA (1) UA42722C2 (no)
WO (1) WO1994026704A1 (no)
ZA (1) ZA943241B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518988A1 (de) * 1995-05-29 1996-12-05 Basf Ag Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
SI2011796T1 (sl) * 2006-04-26 2015-02-27 Toyama Chemical Co., Ltd. Induktor nevrogeneze ali terapevtska uäśinkovina proti nevropatiji, vsebujoäśa derivat alkilnega etra ali sol le-tega
CA2926082C (en) 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
GB9309749D0 (en) 1993-06-23
LV11320A (lv) 1996-06-20
JP3606326B2 (ja) 2005-01-05
PL176400B1 (pl) 1999-05-31
EP0715620B1 (en) 1998-10-28
NO305165B1 (no) 1999-04-12
PH30418A (en) 1997-05-09
BR1100306A (pt) 2002-04-02
HU211124A9 (en) 1995-10-30
EP0715620A1 (en) 1996-06-12
DE69414264T2 (de) 1999-03-25
US5652271A (en) 1997-07-29
IL109635A0 (en) 1994-11-11
NZ266776A (en) 1998-02-26
PL311628A1 (en) 1996-03-04
IL109635A (en) 1998-03-10
ATE172719T1 (de) 1998-11-15
ES2124411T3 (es) 1999-02-01
CZ290711B6 (cs) 2002-09-11
SK140795A3 (en) 1996-09-04
ZA943241B (en) 1994-11-14
JP2004331669A (ja) 2004-11-25
CZ293695A3 (en) 1996-06-12
BR9406577A (pt) 1996-01-30
NO954542L (no) 1996-01-10
DE69414264D1 (de) 1998-12-03
FI955429A (fi) 1996-01-03
JPH08510222A (ja) 1996-10-29
AU6843394A (en) 1994-12-12
AU681669B2 (en) 1997-09-04
FI955429A0 (fi) 1995-11-10
RO115519B1 (ro) 2000-03-30
MY110773A (en) 1999-03-31
SK281257B6 (sk) 2001-01-18
DK0715620T3 (da) 1999-07-05
WO1994026704A1 (en) 1994-11-24
TW318833B (no) 1997-11-01
BG100127A (bg) 1996-07-31
KR100295264B1 (ko) 2001-09-17
RU2135467C1 (ru) 1999-08-27
BG61913B1 (bg) 1998-09-30
UA42722C2 (uk) 2001-11-15

Similar Documents

Publication Publication Date Title
FR2734816B1 (fr) Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI952204A (fi) Terapeuttisia aineita
GB9705428D0 (en) Therapeutic agents
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
NO954542L (no) 1-Arylcykloalkylsulfider, -sulfoksyder og sulfoner for behandling av depresjon, angst og Parkinson's sykdom
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
PL322944A1 (en) Benzimidazolic compounds, pharmaceutic compositions containing such compounds and their application
LV11323A (lv) Izohinolina atvasinajumi ka arstnieciskie lidzekli
JO1809B1 (en) Therapeutic agents
CA2162706A1 (en) 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
ES2116880A1 (es) Farmacos y composiciones farmaceuticas para su uso en el tratamiento de enfermedades.
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
PT1282625E (pt) Benzoxazinas para utilizacao no tratamento da doenca de parkinson
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
MX9708618A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.

Legal Events

Date Code Title Description
MK1K Patent expired